NO922941D0 - Medikamenter og fremgangsmaater for behandling av aids og aids-relatert kompleks ved anvendelse av anti-karbohydrat-antistoffer og karbohydrat-antigener - Google Patents
Medikamenter og fremgangsmaater for behandling av aids og aids-relatert kompleks ved anvendelse av anti-karbohydrat-antistoffer og karbohydrat-antigenerInfo
- Publication number
- NO922941D0 NO922941D0 NO1992922941A NO922941A NO922941D0 NO 922941 D0 NO922941 D0 NO 922941D0 NO 1992922941 A NO1992922941 A NO 1992922941A NO 922941 A NO922941 A NO 922941A NO 922941 D0 NO922941 D0 NO 922941D0
- Authority
- NO
- Norway
- Prior art keywords
- aids
- carbohydrate
- medicinals
- procedures
- treatment
- Prior art date
Links
- 208000030507 AIDS Diseases 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 150000001720 carbohydrates Chemical class 0.000 title abstract 2
- 206010001513 AIDS related complex Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002649 immunization Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47066690A | 1990-01-26 | 1990-01-26 | |
| PCT/EP1990/002161 WO1991011528A1 (en) | 1990-01-26 | 1990-12-13 | Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids-related complex (arc) employing anti-carbohydrate antibodies and carbohydrate antigens |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO922941D0 true NO922941D0 (no) | 1992-07-24 |
| NO922941L NO922941L (no) | 1992-09-17 |
Family
ID=23868522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92922941A NO922941L (no) | 1990-01-26 | 1992-07-24 | Medikamenter og fremgangsmaater for behandling av aids og aids-relatert kompleks (arc) ved anvendelse av anti-karbohydrat-antistoffer og karbohydratantigener |
Country Status (10)
| Country | Link |
|---|---|
| EP (2) | EP0511967B1 (no) |
| JP (2) | JPH05506565A (no) |
| AT (1) | ATE134649T1 (no) |
| AU (1) | AU653141B2 (no) |
| CA (2) | CA2074512A1 (no) |
| DE (1) | DE69025629T2 (no) |
| ES (1) | ES2082962T3 (no) |
| FI (1) | FI923348A (no) |
| NO (1) | NO922941L (no) |
| WO (2) | WO1991011528A1 (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2044741A1 (en) * | 1990-06-18 | 1991-12-19 | Jade Chin | Hiv gp120 monoclonal antibodies |
| JP2002530071A (ja) | 1998-11-13 | 2002-09-17 | クラウセン、ヘンリク | ＵＤＰガラクトース：β−Ｎ−アセチル−グルコサミンβ１，３ガラクトシルトランスフェラーゼ、β３Ｇａｌ−Ｔ５ |
| US6800468B1 (en) | 1998-11-13 | 2004-10-05 | Henrik Clausen | UDP-galactose: β-N-acetyl-glucosamine β1,3galactosyltransferases, β3Gal-T5 |
| WO2005078443A1 (en) * | 2004-02-13 | 2005-08-25 | Inverness Medical Switzerland Gmbh | Determination of infection by the immune response to a carbohydrate moiety |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH083487B2 (ja) * | 1987-07-31 | 1996-01-17 | 株式会社日本抗体研究所 | 異常応答リンパ球の検出方法並びにこれに用いる検出用試薬及びキット |
| WO1989008711A1 (en) * | 1988-03-11 | 1989-09-21 | The Biomembrane Institute | Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates |
-
1990
- 1990-12-13 AT AT91900749T patent/ATE134649T1/de not_active IP Right Cessation
- 1990-12-13 CA CA002074512A patent/CA2074512A1/en not_active Abandoned
- 1990-12-13 DE DE69025629T patent/DE69025629T2/de not_active Expired - Fee Related
- 1990-12-13 AU AU69614/91A patent/AU653141B2/en not_active Ceased
- 1990-12-13 EP EP91900749A patent/EP0511967B1/en not_active Expired - Lifetime
- 1990-12-13 ES ES91900749T patent/ES2082962T3/es not_active Expired - Lifetime
- 1990-12-13 JP JP91501229A patent/JPH05506565A/ja active Pending
- 1990-12-13 WO PCT/EP1990/002161 patent/WO1991011528A1/en active IP Right Grant
-
1991
- 1991-01-24 EP EP19910903499 patent/EP0512023A4/en not_active Ceased
- 1991-01-24 CA CA002073459A patent/CA2073459A1/en not_active Abandoned
- 1991-01-24 WO PCT/US1991/000373 patent/WO1991011199A1/en not_active Application Discontinuation
- 1991-01-24 JP JP91503601A patent/JPH05506843A/ja active Pending
-
1992
- 1992-07-23 FI FI923348A patent/FI923348A/fi not_active Application Discontinuation
- 1992-07-24 NO NO92922941A patent/NO922941L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69025629T2 (de) | 1996-07-04 |
| WO1991011528A1 (en) | 1991-08-08 |
| EP0512023A4 (en) | 1993-06-30 |
| FI923348A0 (fi) | 1992-07-23 |
| DE69025629D1 (de) | 1996-04-04 |
| WO1991011199A1 (en) | 1991-08-08 |
| EP0511967B1 (en) | 1996-02-28 |
| JPH05506565A (ja) | 1993-09-30 |
| ATE134649T1 (de) | 1996-03-15 |
| NO922941L (no) | 1992-09-17 |
| EP0511967A1 (en) | 1992-11-11 |
| AU653141B2 (en) | 1994-09-22 |
| CA2074512A1 (en) | 1991-07-27 |
| JPH05506843A (ja) | 1993-10-07 |
| FI923348A (fi) | 1992-07-23 |
| CA2073459A1 (en) | 1991-07-27 |
| ES2082962T3 (es) | 1996-04-01 |
| EP0512023A1 (en) | 1992-11-11 |
| AU6961491A (en) | 1991-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO944475L (no) | Kombinerte vaksiner omfattende Hepatit B overflateantigen og andre antigener | |
| DK0528767T3 (da) | antistofderivater | |
| NO941877L (no) | Type I og type II overflateantigener i forbindelse med Staphylococcus Epidermidis | |
| NO302176B1 (no) | Fremgangsmåte for fremstilling av et monoklonalt antistoff og et antigen | |
| DK98187D0 (da) | Monoklonale antistoffer og antigen for human ikke-smaacellet lungecarcinoma og visse andre typer human carcinoma | |
| DK0474691T3 (da) | Monoklonale antistoffer til induktion af tolerance | |
| NO922941D0 (no) | Medikamenter og fremgangsmaater for behandling av aids og aids-relatert kompleks ved anvendelse av anti-karbohydrat-antistoffer og karbohydrat-antigener | |
| DK140992D0 (da) | Fremgangsmaade til frembringelse af antistoffer mod haptener og andre b-celle-antigener, antistoffer opnaaet ved fremgangsmaaden og anvendelse af disse antistoffer til fremstilling af vacciner, isaer til veterinaermedicinsk brug | |
| JPS6463392A (en) | Monoclonal antibody against specific antigen for human immunodeficiency virus | |
| NO915017D0 (no) | Monoklonale antistoffer og fremgangsmaate for deres fremstilling | |
| DE3485712D1 (de) | Monoklonale antikoerper gegen menschliche nierenkrebsantigene und verfahren. | |
| EP0511300A4 (en) | Monoclonal antibody specific for non-immunodominant epitope of hiv proteins | |
| DE3851630D1 (de) | Antikörper gegen streptococcus. | |
| FI952171A0 (fi) | Hepatiitti B-pinta-antigeeneille aktiivisten ihmisen monoklonaalisten vasta-aineiden tuotto | |
| DK0537168T3 (da) | Antigenet CTAA 28A32, som genkendes af MCA 28A32 | |
| DK0644947T3 (da) | Anti-idiotypiske monoklonale antistoffer mod det Lewis Y-specifikke monoklonale antistof BR55-2 og deres anvendelser | |
| EP0307476A4 (en) | Bilirubin antigen, monoclonal antibody therefor, process for their preparation, and their use | |
| ES2013665A6 (es) | Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso. | |
| EP0334076A3 (en) | Monoclonal antibody capable of recognizing an antigen associated with human arteriosclerosis, and process for preparing the same | |
| IT1254570B (it) | Antigeni legati alla superfice esterna di eritrociti e procedimento per la loro preparazione. | |
| ATE110786T1 (de) | Monoklonaler antikörper gegen exotoxin a von pseudomonas aeruginosa. | |
| DE3777196D1 (de) | Anti-parathyroid-antikoerper-praeparat. | |
| IT1254955B (it) | Anticorpi monoclonali murini diretti contro il polisaccaride capsulare di streptococchi di gruppo b di tipo iii | |
| BG51731A1 (en) | Hybridome cellular line mus musculus balb/c, secreting monoclonal antibody against antigenic deternimant, common for the strains hantaan and finnish of the virus of haemorrhagic fever with nephritic syndrome | |
| NO930883D0 (no) | Peptider for bruk ved vaksinasjon og induksjon av noeytraliserende antistoffer mot hiv |